Skip to main content
SpringerLink
Log in

Alternative funding considered for cystic fibrosis drug in England

  • News item
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. see PharmacoEconomics & Outcomes News 837 p34; 803422680

Reference

  • Cohen D. NHS England explores funding options for cystic fibrosis drug. BMJ : 17 Sep 2019. Available from: URL: https://doi.org/10.1136/bmj.l5600

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Alternative funding considered for cystic fibrosis drug in England. PharmacoEcon Outcomes News 838, 33 (2019). https://doi.org/10.1007/s40274-019-6278-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-019-6278-7

Search

Navigation